Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics
The Fly

Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics

Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: “There have been vague whispers of bid interest for $TGTX from AstraZeneca (AZN), GSK (GSK) and Novartis (NVS) although the hot money is on a move from Roche at upwards of $60 a share. Banks including JP Morgan and Goldman Sachs are rumoured to be involved….” Shares of TG Therapeutics (TGTX) trading in New York are up 4% to $32.16.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App